Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjunctive Treatment of Major Depressive Disorder”

142 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 142 results

Testing effectiveness (Phase 2)Study completedNCT03227224
What this trial is testing

Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 287
Large-scale testing (Phase 3)Study completedNCT01072630
What this trial is testing

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Who this might be right for
Depression
Cephalon 492
Large-scale testing (Phase 3)Study completedNCT02013531
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Who this might be right for
Major Depressive DisorderAnxiety
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Large-scale testing (Phase 3)Study completedNCT02943577
What this trial is testing

Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)

Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 429
Large-scale testing (Phase 3)Study completedNCT01360866
What this trial is testing

Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)

Who this might be right for
Depressive DisorderDepressionDepressive Disorder, Major+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 2,944
Large-scale testing (Phase 3)Study completedNCT01370499
What this trial is testing

LY2216684 in Participants With Major Depression Disorder

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 288
Testing effectiveness (Phase 2)Study completedNCT04103892
What this trial is testing

CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder
Clexio Biosciences Ltd. 146
Testing effectiveness (Phase 2)Study completedNCT02473289
What this trial is testing

An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 193
Large-scale testing (Phase 3)Study completedNCT05550532
What this trial is testing

Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Who this might be right for
Depressive Disorder, MajorAnhedonia
Janssen Research & Development, LLC 444
Large-scale testing (Phase 3)Looking for participantsNCT06911112
What this trial is testing

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Neurocrine Biosciences 200
Testing effectiveness (Phase 2)Study completedNCT01582815
What this trial is testing

JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms

Who this might be right for
Major Depressive Disorder
Janssen Research & Development, LLC 121
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06168175
What this trial is testing

Feasibility of Conducting a Clinical Trial Assessing Efficacy of Lactate as Adjunctive Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Centre Hospitalier Universitaire Vaudois 46
Testing effectiveness (Phase 2)Study completedNCT02805439
What this trial is testing

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Who this might be right for
Major Depressive Disorder
Institut de Recherches Internationales Servier 400
Large-scale testing (Phase 3)Ended earlyNCT03668600
What this trial is testing

Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)

Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 230
Large-scale testing (Phase 3)Ended earlyNCT06011577
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD

Who this might be right for
Major Depressive DisorderDepression
Levomecor Inc. 27
Not applicableStudy completedNCT02176408
What this trial is testing

Efficacy of Adjunctive Exercise for the Behavioral Treatment of Major Depression

Who this might be right for
Major Depressive Disorder
Boston University Charles River Campus 38
Testing effectiveness (Phase 2)Study completedNCT03321526
What this trial is testing

Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 107
Large-scale testing (Phase 3)Study completedNCT04688164
What this trial is testing

Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Relmada Therapeutics, Inc. 227
Early research (Phase 1)Study completedNCT01670279
What this trial is testing

Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 18
Large-scale testing (Phase 3)WithdrawnNCT02212613
What this trial is testing

Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability

Who this might be right for
Major Depressive Disorder and Irritability
Otsuka Pharmaceutical Development & Commercialization, Inc.
Load More Results